Delivery Order SPE2DE24D0013-SPE2D625F8UP6
- Not listed
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a firm fixed-price delivery order valued at $1,843.36 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, issued on September 18, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. The delivery order will be performed in Sunnyvale and represents a continuation of Cepheid's ongoing provision of diagnostic equipment,...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $81,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems. Issued on September 5, 2025, with an ultimate completion date of September 12, 2025, this delivery order (Contract No. 4569359238) carries no set-aside designation and represents a continuation of the government's procurement of Cepheid's diagnostic solutions. The work will be performed at...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $13,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. Issued on August 14, 2025, with an ultimate completion date of August 21, 2025, this delivery order (XPRS4PLEX-10) carries no set-aside designation and represents a short-term procurement under one of Cepheid's existing indefinite delivery vehicle contracts. The place of performance is Sunnyvale,...
- The U.S. Defense Logistics Agency (under the Medical Supply Chain division) awarded a firm fixed-price delivery order valued at $8,820.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on August 21, 2025, with an ultimate completion date of August 28, 2025, carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a continuation of Cepheid's ongoing...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,815 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 7, 2025, with ultimate completion targeted for August 21, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with one of Cepheid's existing Indefinite Delivery Vehicle contracts with...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $26,627.40 delivery order (XPRSMVP-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with a completion date of September 26, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of the agency's procurement of diagnostic testing solutions from Cepheid, a company specializing in advanced molecular diagnostic systems and...
- The U.S. Department of Defense Medical Supply Chain awarded a $1,155 firm fixed-price delivery order to Cepheid Inc. on June 16, 2025, with an ultimate completion date of June 24, 2025. Cepheid, a for-profit manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California, specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing. The contract carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility....
- The U.S. Defense Department's Medical Supply Chain has awarded a $5,082 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, for SARS-CoV-2 testing supplies. The contract, awarded on August 4, 2025, with an ultimate completion date of August 18, 2025, carries no set-aside designation and will be performed at Cepheid's primary facility in Sunnyvale. This delivery order falls under Cepheid's existing indefinite delivery vehicle...
- The U.S. Defense Medical Supply Chain awarded a $1,854 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is associated with Cepheid's broader federal contracting portfolio, which includes two significant Indefinite...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F8UP6Delivery Order
The U.S. Defense agency's Medical Supply Chain issued a delivery order valued at $4,901.39 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, under contract number GXCT/NG-10. This firm fixed-price delivery order, awarded on July 25, 2025, with an ultimate completion date of August 1, 2025, carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale, California. Cepheid specializes in providing advanced molecular diagnostic systems and test kits for infectious diseases and clinical testing applications. The company maintains substantial ongoing relationships with federal healthcare agencies through two significant Indefinite Delivery Vehicle contracts: a $32.8 million single-award IDV with the VA's Veterans Integrated Service Network 6 extending through September 30, 2030, and a $2.5 million IDV with VA's Veterans Integrated Service Network 21 focused on PCR testing capabilities. Cepheid's federal contract portfolio historically emphasizes diagnostic equipment, reagents, assays, and testing services for detecting conditions including COVID-19, influenza, RSV, and other infectious diseases across multiple VA networks and Defense Logistics Agency programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 7/25/25 |